COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" (External organisation)

Activity: Membership types › Membership of network

Description

COST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies" Representative of Latvia in the Steering Committee
Period19 Oct 2017 → 18 Apr 2022
Held atCOST Action CA16225 "Realising the therapeutic potential of novel cardioprotective therapies", Belgium
Degree of RecognitionInternational